Poly Medicure peers

Companies like Poly Medicurelatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

POLYMED₹1,461.90

Poly Medicure Ltd.

· Pharma & Health
₹ CrorePeersPFIZERRAINBOWONESOURCEKIMSJUBLPHARMAVIJAYAINDGNGRANULESMcap ₹14,818 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
POLYMED
FY26
PFIZER
FY26
RAINBOW
FY26
ONESOURCE
FY26
Peer
Average
Valuation — at last close
P/E45.99×—◆ 43.66×—43.66× +5%
P/B4.77×—7.37×◆ 3.09×5.23× -9%
EV/EBITDA32.50×—◆ 21.56×62.99×42.28× -23%
Market Cap₹14,818 Cr—₹12,155 Cr₹17,991 Cr₹15,073 Cr -2%
Growth
Revenue CAGR 3Y◆ 18.91%1.29%13.22%—7.26% +161%
Revenue CAGR 5Y◆ 18.98%2.39%——2.39% +694%
Net Income CAGR 3Y◆ 21.39%5.01%9.85%—7.43% +188%
Revenue YoY (latest Q)30.30%—33.17%◆ 37.39%35.28% -14%
Net Income YoY (latest Q)-8.39%—16.23%◆ 448.25%232.24% -104%
Profitability
EBITDA Margin23.59%◆ 35.88%31.95%21.40%29.74% -21%
Net Income Margin17.10%◆ 28.67%16.53%-5.19%13.34% +28%
Return on Common Equity10.97%17.16%◆ 17.86%-1.26%11.25% -3%
Return on Capital Employed10.60%◆ 19.60%16.34%0.38%12.11% -12%
Return on Assets9.02%◆ 14.69%10.93%-0.94%8.23% +10%
Credit & Quality
Total Debt/Equity0.11×◆ 0.00×0.00×0.22×0.07× +50%
Interest Coverage17.87×◆ 89.28×5.07×0.21×31.52× -43%
Scale — latest FY
Revenue / Total Income₹1,875 Cr₹2,520 Cr₹1,703 Cr₹1,422 Cr₹1,881 Cr 0%
Net Income₹321 Cr₹722 Cr₹282 Cr−₹73.8 Cr₹310 Cr +3%
Total Assets₹3,919 Cr₹4,922 Cr₹2,775 Cr₹8,210 Cr₹5,302 Cr -26%
EPS₹31.79—₹27.41₹-6.44₹10.49 +203%
Book Value per Share₹306.45—₹162.28₹508.75₹335.52 -9%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.